MacuMira ads

Following our European debut at ESCRS, MacuMira is excited to continue connecting with the European ophthalmology community at the 26th European Society of Retina Specialists (EURETINA) Congress, alongside our global partner, Keeler. From 1–4 October, visit us at Booth D17 to meet the MacuMira team and learn more about our approach to addressing the significant unmet need in dry AMD care. At our booth, you can: • See the MacuMira device in action through a live demonstration • Explore our growing body of clinical and real-world evidence • Learn more about the technology behind MacuMira and its approach to supporting visual function in patients with dry AMD • Meet our leadership and commercial team (Matt Van de Ven, Rob Crate, Muhammad Muhammad) to discuss MacuMira and our plans for Europe With more than 30,000 treatments performed globally, we’re looking forward to bringing the MacuMira story to one of the world’s leading retina-focused meetings and connecting with retinal specialists, researchers, partners, and industry leaders from around the world. 📍 EURETINA 2026 | VIECON – Vienna Congress & Convention Center 📅 1–4 October 2026 🔵 MacuMira Booth D17 Want dedicated time with our team while you’re at EURETINA? Book a meeting with us here: 👉 https://lnkd.in/ehdmMQQ9 We look forward to seeing you in Vienna! MacuMira is not currently CE marked. For presentation and demonstration purposes only. Not available on the EU or UK market until brought into compliance with Regulation (EU) 2017/745. #EURETINA2026 #MacuMira #DryAMD #Retina #Ophthalmology #MacularDegeneration #MedicalDevices #EyeCare #RetinalDisease #Innovation #VisionCare

For the first time, MacuMira is coming to Europe, and we’re excited to make our European debut at The European Society of Cataract and Refractive Surgeons (ESCRS) 2026 meeting in London, alongside our global partner, Keeler. From 11–15 September, visit us at Booth D.315 to meet the MacuMira team and experience firsthand what we’ve been building in dry AMD care. At our booth, you can: • See the MacuMira device in action through a live demonstration • Explore our clinical and real-world data • Learn more about the technology behind MacuMira and its approach to supporting visual function in patients with dry AMD • Meet our leadership and commercial team (Matt Van de Ven, Rob Crate, Muhammad Muhammad) to discuss MacuMira and our plans for Europe With more than 30,000 treatments performed globally, we’re incredibly excited to bring the MacuMira story to the European ophthalmology community and connect with clinicians, researchers, partners, and industry leaders from around the world. 📍 ESCRS 2026 | ExCeL London 📅 11–15 September 2026 🔵 MacuMira Booth D.315 🤝 Also find us on the Keeler Booth at D.355 Want dedicated time with our team while you’re at ESCRS? Book a meeting with us here: 👉 https://lnkd.in/ecSisKte We look forward to seeing you in London. MacuMira is not currently CE marked. For presentation and demonstration purposes only. Not available on the EU market until brought into compliance with Regulation (EU) 2017/745. #ESCRS2026 #MacuMira #DryAMD #Ophthalmology #Retina #MacularDegeneration #MedicalDevices #EyeCare #Innovation #VisionCare

For the first time, MacuMira is being showcased in the United States, and we’re excited to introduce our technology to the U.S. ophthalmology community at the American Academy of Ophthalmology 2026 Annual Meeting in New Orleans, alongside our global partner, Keeler. From October 10–13, visit us on Keeler's Booth 837 to learn more about this emerging technology for improving visual function in patients with dry AMD. At the booth, you can: • See the MacuMira device in action • Explore our clinical and real-world data • Learn more about the technology behind MacuMira and its approach to improving visual function in patients with dry AMD • Meet with our leadership team (CEO Matt Van de Ven and CBO Rob Crate) With more than 35,000 treatments performed globally, we’re looking forward to connecting with ophthalmologists, retina specialists, researchers, partners, and industry leaders from across the U.S. and around the world. 📍 AAO 2026 | New Orleans, LA 📅 October 10–13, 2026 🤝 Visit MacuMira on Keeler’s Booth 837 Want dedicated time with our team while you’re at AAO? Book a meeting with us at: https://lnkd.in/gTpQR2qi We look forward to seeing you in New Orleans! MacuMira is not FDA-authorized. For presentation and demonstration purposes only. Not available for sale or clinical use in the United States. #AAO2026 #MacuMira #DryAMD #Ophthalmology #Retina #MacularDegeneration #MedicalDevices #EyeCare #VisionCare

Get the latest jobs and industry news

Every retinal cell communicates through electrical signals. MacuMira was designed to work with those native bioelectric processes, bringing an innovative modality to dry AMD treatment.

The retina relies on bioelectric signaling every second. MacuMira uses microcurrent stimulation designed to work with the retina's native bioelectric processes in dry AMD. Discover a different approach to vision care.